Interplay between influenza virus and S1P-metabolizing enzymes
Interplay between influenza virus and S1P-metabolizing enzymes
批准号:
10426374
负责人:
BUMSUK HAHM
金额:
$44.96万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-10 至 2026-05-31
关键词:
AffectAnimal ModelAttenuatedBiological ProcessDataDevelopmentDiseaseEnvironmentEnzymesEpithelial CellsEventExhibitsFoundationsGoalsHealthHost DefenseHost Defense MechanismHumanImpairmentIn VitroInfectionInfluenzaInnate Immune ResponseIntegration Host FactorsInterferon Type IInterferonsKnockout MiceKnowledgeLyaseMediatingMediator of activation proteinMolecularMorbidity - disease rateMusOutcomePathogenesisPathogenicityPathway interactionsProcessReportingResearchRoleSignal PathwaySignal TransductionSphingolipidsTherapeuticUbiquitinationViralViral PathogenesisViral PhysiologyVirusVirus DiseasesVirus Replicationanti-influenzabasecellular targetingdesignin vivoin vivo Modelinfluenza infectioninfluenzaviruslipid mediatormortalitynovelnovel therapeutic interventionresponsesphingosine 1-phosphatesphingosine kinasesphingosine-1-phosphate lyasetargeted treatmentvirus host interaction
中文摘要
项目摘要
流感作为对人类健康的全球威胁,继续造成严重的发病率和高发病率。
死亡率。要有效地控制流感,重要的是要了解宿主和
通过确定调节病毒复制的宿主因素和定义
流感病毒操纵细胞防御或信号通路。鞘脂是一种生物活性脂类。
介质,包括鞘氨醇1-磷酸(S1P)。虽然S1P及其代谢酶,如
S1P裂解酶(SPL)和鞘氨醇激酶2(SK2)被报道调节多种细胞或疾病
这些过程在流感病毒感染中的作用还知之甚少。初步数据表明,SPL
促进IKKε介导的I型干扰素反应以显示抗流感病毒活性。然而,
流感病毒有效下调SPL,表明流感病毒努力逃避宿主
防御机制。此外,流感病毒还增加了另一种S1P代谢酶的水平,
SK2,加速了流感病毒的复制。SK2抑制流感病毒增殖的实验研究
并提高了病毒感染小鼠的存活率,证明了SK2的亲流感作用。这些
这些发现增强了进一步研究S1P代谢酶、宿主之间相互作用的必要性
防御和信号,以及流感病毒。本方案的研究目的包括:1)确定
流感病毒操纵SP1和SK2促进病毒复制的机制,2)调查
这些S1P代谢酶如何显示抗病毒或亲流感病毒活性的机制,以及
3)确定S1P代谢酶在流感病毒体内感染过程中的作用。
总的来说,这些研究结果可以定义S1P代谢酶的调节功能,
影响宿主防御和流感致病性。此外,该项目可以为
设计新的治疗措施来治愈流感。
英文摘要
Project Summary
Influenza, as a global threat to human health, continues to cause significant morbidity and high rates of
mortality. To effectively control influenza, it is important to understand the interplay between the host and
influenza by identifying host factors that regulate viral replication and defining the mechanisms by which
influenza virus manipulates the cellular defense or signaling pathway. Sphingolipids are bioactive lipid
mediators and include sphingosine 1-phosphate (S1P). Although S1P and its metabolizing enzymes, such as
S1P lyase (SPL) and sphingosine kinase 2 (SK2), have been reported to regulate versatile cellular or disease
processes, their roles in influenza virus infection are poorly understood. Preliminary data indicate that SPL
promoted IKKε-mediated type I interferon (IFN) responses to display anti-influenza viral activity. However,
influenza viruses effectively downregulated SPL, suggesting that influenza virus strives to evade the host
defense mechanism. Furthermore, influenza virus increased the level of another S1P-metabolizing enzyme,
SK2, which accelerated influenza virus replication. Inhibition of SK2 impaired influenza virus propagation in
vitro and increased the viability of virus-infected mice, demonstrating the pro-influenza function of SK2. These
findings heighten the need to further investigate the interplay between the S1P-metabolizing enzymes, host
defense and signaling, and influenza virus. The research aims of this proposal include 1) determining the
mechanisms by which influenza virus manipulates SPL and SK2 to enhance virus replication, 2) investigating
the mechanisms of how these S1P-metabolizing enzymes display antiviral or pro-influenza viral activities, and
3) establishing the functions of the S1P-metabolizing enzymes during influenza virus infection in vivo.
Collectively, these research results can define the regulatory functions of S1P-metabolizing enzymes that
impact host defenses and influenza pathogenicity. Furthermore, the project could provide a foundation for
designing new therapeutic interventions to cure influenza.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of host immunity to impact virus persistence
-
批准号:10293370
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2021
-
负责人:BUMSUK HAHM
-
依托单位:
Interplay between influenza virus and S1P-metabolizing enzymes
-
批准号:10625453
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2021
-
负责人:BUMSUK HAHM
-
依托单位:
Regulation of host immunity to impact virus persistence
-
批准号:10424601
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2021
-
负责人:BUMSUK HAHM
-
依托单位:
Interplay between influenza virus and S1P-metabolizing enzymes
-
批准号:10271756
-
项目类别:
-
资助金额:$42.03万
-
财政年份:2021
-
负责人:BUMSUK HAHM
-
依托单位:
Regulation of host immunity to impact virus persistence
-
批准号:10640180
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2021
-
负责人:BUMSUK HAHM
-
依托单位:
Control of influenza virus by sphingolipid metabolism
-
批准号:8452117
-
项目类别:
-
资助金额:$34.5万
-
财政年份:2011
-
负责人:BUMSUK HAHM
-
依托单位:
Control of influenza virus by sphingolipid metabolism
-
批准号:8260847
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2011
-
负责人:BUMSUK HAHM
-
依托单位:
Control of influenza virus by sphingolipid metabolism
-
批准号:8182069
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2011
-
负责人:BUMSUK HAHM
-
依托单位:
Novel modulation of dendritic cell response against a chronic virus infection
-
批准号:8071193
-
项目类别:
-
资助金额:$17.73万
-
财政年份:2010
-
负责人:BUMSUK HAHM
-
依托单位:
Novel modulation of dendritic cell response against a chronic virus infection
-
批准号:7867779
-
项目类别:
-
资助金额:$21.18万
-
财政年份:2010
-
负责人:BUMSUK HAHM
-
依托单位:
海外基金